Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04489329
Other study ID # REB 20-1211
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 22, 2020
Est. completion date February 24, 2021

Study information

Verified date September 2021
Source Nimble Science Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Proof of concept study to validate the ability of a capsule device to gather samples from the small bowel for microbiome analysis in adults and to detect dietary changes from simultaneous ingestion of a probiotic.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date February 24, 2021
Est. primary completion date February 24, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: 1. 18 to 65 years old 2. Healthy 3. On no medication, or on stable doses of medications which will not be changed over the course of the study 4. Willingness to maintain their usual dietary habits and physical activity 5. Willing to discontinue consumption of fermented foods or probiotics (such as kombucha, yogurts with live, active cultures, or probiotic supplements) for the duration of the study. 6. Ability to understand and provide informed consent 7. Ability and willingness to meet the required schedule and study tasks and interventions 8. Willing to fast for at least 8 hours before the 2 intake visits (Visit 1 and Visit 2) Exclusion Criteria: 1. History of a small intestine obstruction of symptoms of an intermittent small intestine obstruction (i.e., recurrent abdominal pain, distention, nausea and vomiting). 2. Pregnant or breastfeeding or planning on becoming pregnant during study timeline. 3. Use of other investigational product within 3 months of start of the study. 4. Suffering from immune disorders or with possible immune deficient status 5. Allergy to soy or milk. 6. Prior gastrointestinal surgery which has altered the anatomy of the esophagus, stomach or small or large intestine (exceptions include appendectomy or cholecystectomy more than 3 months prior to enrollment). 7. Use of any medications in the previous 7 days that could substantially alter gastrointestinal motor function (e.g. opioids, prokinetics, anticholinergics, laxatives), acidity (PPI, H2RA), or integrity (NSAIDs, oral steroids). 8. Body Mass Index (BMI) > 38. 9. Previous history of gastric bezoar or gastroparesis. 10. Any abdominal or pelvic surgery within the past 3 months. 11. Known history of inflammatory bowel disease and/or Crohn's disease. 12. History of diverticulitis, diverticular stricture, or other intestinal strictures. 13. History of abdominal or pelvic radiotherapy. 14. History of dysphagia, eosinophilic esophagitis, esophageal stricture, or other swallowing disorder. 15. Cardiovascular, endocrine, renal or other chronic disease likely to affect motility. 16. Colon cleansing prep for 1 month before the first visit, or during the study. 17. Use of antibiotics, prebiotics, herbal supplements, or probiotics for 2 weeks before the first visit, or during the study. 18. < 2 bowel movements per week.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Ingestible Capsule
Participants will swallow capsule and undergo X-rays to establish transit
Dietary Supplement:
Probiotic
Participants will swallow a probiotic capsule and the sample collection capsule at the same time to establish concentration of strain in small intestine.

Locations

Country Name City State
Canada Cumming School of Medicine Calgary Alberta

Sponsors (3)

Lead Sponsor Collaborator
Nimble Science Ltd. Lallemand Health Solutions, University of Calgary

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Bacterial density count density count of probiotic strain compared between capsule and stool sample (CFU/ml) 7 days
See also
  Status Clinical Trial Phase
Completed NCT04094558 - Validation of the Small Intestine Microbiome Aspiration (SIMBA) Capsule N/A